Replies to post #212105 on Biotech Values

[DewDiligence]

That remains to be seen; however, companies other than MNTA have not, to my knowledge, conducted the kinds of switching studies mandated by the FDA's draft guidance on interchangeable FoBs (#msg-127945401).